Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.

INO-4800 - Inovio, The Wistar Institute

http://www.ncbi.nlm.nih.gov/pubmed/39865693

Bin Wang; Chengwei Shao; Danjing Leng; Fengcai Zhu; Gan Zhao; Hongxing Pan; Jianfang Xu; Jiarong Wang; Jingxin Li; Siyue Jia; Xin Cheng; Xuefen Huai; Yu Xia; Zhijian Wang

Jan 27, 2025